Study evaluated the effects of exposure to perfluoroalkyl substances on asthma phenotypes.
Moderna wants an accelerated approval for its cancer vaccine — but it’s waiting on three things
Moderna has touted the possibility of an accelerated approval for its Merck-partnered cancer vaccine by 2025. But according to executives, three things need to happen